SYK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Stryker Corp (SYK) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, diversified growth product portfolio, and positive sentiment from analysts outweigh the minor negative catalysts such as hedge fund selling and slightly compressed gross margins. The stock's pre-market price of $386.8 is near recent analyst price targets, and the company's consistent growth trends make it a solid long-term investment.
The MACD is positively contracting and above 0, indicating a bullish trend. The RSI is neutral at 74.48, and moving averages are converging, suggesting no immediate overbought or oversold conditions. The stock is trading near its first resistance level (R1: 385.683), with a pivot at 376.461, indicating a stable upward trend.
Analysts have raised price targets, with several maintaining Buy or Outperform ratings.
Stryker's Q4 2025 financials show strong revenue growth (11.42% YoY), net income growth (55.49% YoY), and EPS growth (56.03% YoY).
Launch of the Synchfix EVT device, which enhances surgical efficiency and patient safety, adds to the company's diversified product portfolio.
Hedge funds are selling, with a 119.77% increase in selling activity over the last quarter.
Gross margin slightly declined by -0.46% YoY in Q4 2025.
In Q4 2025, Stryker reported revenue of $7.171 billion (up 11.42% YoY), net income of $849 million (up 55.49% YoY), and EPS of $2.2 (up 56.03% YoY). Gross margin slightly declined to 62.61% (-0.46% YoY), but overall financial performance remains robust.
Analysts are generally positive on Stryker. UBS raised its price target to $400, Barclays to $469, and BTIG to $412, among others. William Blair initiated coverage with an Outperform rating, citing faster sales and earnings growth versus peers. However, TD Cowen downgraded the stock to Hold, citing valuation concerns, though the firm acknowledged the company's strong fundamentals.
